Market Overview:
The global DNA polymerase reagent kit market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for DNA sequencing and PCR products, rising prevalence of genetic disorders, and technological advancements in the field of molecular biology. Based on type, the global DNA polymerase reagent kit market can be segmented into buffer solution, antibody, and other segments. The buffer solution segment is expected to account for a major share of the global market due to its wide use in PCR and sequencing applications. By application, hospitals and medical centers are expected to account for a major share of the global DNA polymerase reagent kit market due to rising demand for these products from diagnostic laboratories.
Product Definition:
A DNA polymerase reagent kit is a laboratory tool used to amplify target DNA sequences. The importance of this tool lies in its ability to replicate DNA strands quickly and accurately, making it an essential component of many molecular biology experiments.
Buffer Solution:
The global buffer solution, it's usage and growth factor in DNA polymerase reagent kit market size was valued at USD 4.5 billion in 2015. The increasing demand for the Polymerase Chain Reaction (PCR) technology across various life science research applications is expected to drive the market growth over the forecast period.
Antibody:
Antibody is an immunoglobulin produced by the body in response to an antigen. The most commonly used antibodies are those that bind to a particular protein or antigen and can be transported through the blood and tissues for further action. Antibodies are proteins, which are made by B cells (B lymphocytes) and plasma cells ( Plasma cell disorders include chronic inflammatory demyelinating polyneuropathy (CIDP), primary immune deficiency, multiple sclerosis, etc.
Application Insights:
The hospitals and medical centers segment dominated the global DNA polymerase reagent kit market in 2017. This can be attributed to factors such as rising prevalence of chronic diseases, increasing number of surgeries, and growing expenditure on healthcare. Increasing investments by governments in building new hospitals and upgrading existing facilities will also boost product demand over the forecast period.
Increasing investment by governments in building new hospital infrastructure is expected to drive demand for PCR systems which will eventually benefit manufacturers of DNA polymerase enzyme products such as KAPA Biosystems Inc., Life Technologies Corporation, PerkinElmer Inc., Roche Applied Sciences), etc. The academic and research institutes segment are anticipated to witness lucrative growth over the forecast period due to rise in R&D activities relatedto genetic disorders affecting humans particularly across regions including Latin America, Middle East & Africa, Europe).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a substantial number of academic and research institutes, which have led to an increase in funding for genomic tests. Moreover, increasing prevalence of cancer is also expected to drive regional growth over the forecast period. For instance, according to Cancer Statistics Canada’s estimates published in 2018, 1 out of 4 Canadians will be diagnosed with cancer during their lifetime and it accounts for about 1 death every 2 minutes.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to factors such as economic development.
Growth Factors:
- Increasing demand for DNA sequencing and polymerase chain reaction (PCR) techniques for research and diagnostic purposes
- Rising prevalence of genetic disorders and cancer
- Growing number of biotechnology and pharmaceutical companies investing in R&D activities for novel drug discovery
- Technological advancements in DNA sequencing platforms that are driving down the cost of sequencing
- Increasing use of polymerase reagents in personalized medicine
Scope Of The Report
Report Attributes
Report Details
Report Title
DNA Polymerase Reagent kit Market Research Report
By Type
Buffer Solution, Antibody, Other
By Application
Hospitals and Medical Centers, Clinical Laboratories, Academic and Research Institutes
By Companies
Hangzhou Matridx Biotechnology Co.,Ltd, ADS Biotec Inc, BioTeke Corporation(wuxi) Co.,Ltd, GeneDireX, TransGen Biotech Co., Ltd, Takara Bio Inc, Kaneka Eurogentec S.A., MGI Tech Co., Ltd, Canvax, BIONEER CORPORATION, PCR Biosystems, PacBio
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
152
Number of Tables & Figures
107
Customization Available
Yes, the report can be customized as per your need.
Global DNA Polymerase Reagent kit Market Report Segments:
The global DNA Polymerase Reagent kit market is segmented on the basis of:
Types
Buffer Solution, Antibody, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Medical Centers, Clinical Laboratories, Academic and Research Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Hangzhou Matridx Biotechnology Co.,Ltd
- ADS Biotec Inc
- BioTeke Corporation(wuxi) Co.,Ltd
- GeneDireX
- TransGen Biotech Co., Ltd
- Takara Bio Inc
- Kaneka Eurogentec S.A.
- MGI Tech Co., Ltd
- Canvax
- BIONEER CORPORATION
- PCR Biosystems
- PacBio
Highlights of The DNA Polymerase Reagent kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Buffer Solution
- Antibody
- Other
- By Application:
- Hospitals and Medical Centers
- Clinical Laboratories
- Academic and Research Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the DNA Polymerase Reagent kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The DNA Polymerase Reagent kit is a set of reagents used in molecular biology to amplify DNA.
Some of the major players in the dna polymerase reagent kit market are Hangzhou Matridx Biotechnology Co.,Ltd, ADS Biotec Inc, BioTeke Corporation(wuxi) Co.,Ltd, GeneDireX, TransGen Biotech Co., Ltd, Takara Bio Inc, Kaneka Eurogentec S.A., MGI Tech Co., Ltd, Canvax, BIONEER CORPORATION, PCR Biosystems, PacBio.
The dna polymerase reagent kit market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 DNA Polymerase Reagent kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 DNA Polymerase Reagent kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 DNA Polymerase Reagent kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the DNA Polymerase Reagent kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global DNA Polymerase Reagent kit Market Size & Forecast, 2018-2028
4.5.1 DNA Polymerase Reagent kit Market Size and Y-o-Y Growth
4.5.2 DNA Polymerase Reagent kit Market Absolute $ Opportunity
Chapter 5 Global DNA Polymerase Reagent kit Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 DNA Polymerase Reagent kit Market Size Forecast by Type
5.2.1 Buffer Solution
5.2.2 Antibody
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global DNA Polymerase Reagent kit Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 DNA Polymerase Reagent kit Market Size Forecast by Applications
6.2.1 Hospitals and Medical Centers
6.2.2 Clinical Laboratories
6.2.3 Academic and Research Institutes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global DNA Polymerase Reagent kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 DNA Polymerase Reagent kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America DNA Polymerase Reagent kit Analysis and Forecast
9.1 Introduction
9.2 North America DNA Polymerase Reagent kit Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America DNA Polymerase Reagent kit Market Size Forecast by Type
9.6.1 Buffer Solution
9.6.2 Antibody
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America DNA Polymerase Reagent kit Market Size Forecast by Applications
9.10.1 Hospitals and Medical Centers
9.10.2 Clinical Laboratories
9.10.3 Academic and Research Institutes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe DNA Polymerase Reagent kit Analysis and Forecast
10.1 Introduction
10.2 Europe DNA Polymerase Reagent kit Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe DNA Polymerase Reagent kit Market Size Forecast by Type
10.6.1 Buffer Solution
10.6.2 Antibody
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe DNA Polymerase Reagent kit Market Size Forecast by Applications
10.10.1 Hospitals and Medical Centers
10.10.2 Clinical Laboratories
10.10.3 Academic and Research Institutes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific DNA Polymerase Reagent kit Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific DNA Polymerase Reagent kit Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific DNA Polymerase Reagent kit Market Size Forecast by Type
11.6.1 Buffer Solution
11.6.2 Antibody
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific DNA Polymerase Reagent kit Market Size Forecast by Applications
11.10.1 Hospitals and Medical Centers
11.10.2 Clinical Laboratories
11.10.3 Academic and Research Institutes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America DNA Polymerase Reagent kit Analysis and Forecast
12.1 Introduction
12.2 Latin America DNA Polymerase Reagent kit Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America DNA Polymerase Reagent kit Market Size Forecast by Type
12.6.1 Buffer Solution
12.6.2 Antibody
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America DNA Polymerase Reagent kit Market Size Forecast by Applications
12.10.1 Hospitals and Medical Centers
12.10.2 Clinical Laboratories
12.10.3 Academic and Research Institutes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) DNA Polymerase Reagent kit Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) DNA Polymerase Reagent kit Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) DNA Polymerase Reagent kit Market Size Forecast by Type
13.6.1 Buffer Solution
13.6.2 Antibody
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) DNA Polymerase Reagent kit Market Size Forecast by Applications
13.10.1 Hospitals and Medical Centers
13.10.2 Clinical Laboratories
13.10.3 Academic and Research Institutes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 DNA Polymerase Reagent kit Market: Competitive Dashboard
14.2 Global DNA Polymerase Reagent kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Hangzhou Matridx Biotechnology Co.,Ltd
14.3.2 ADS Biotec Inc
14.3.3 BioTeke Corporation(wuxi) Co.,Ltd
14.3.4 GeneDireX
14.3.5 TransGen Biotech Co., Ltd
14.3.6 Takara Bio Inc
14.3.7 Kaneka Eurogentec S.A.
14.3.8 MGI Tech Co., Ltd
14.3.9 Canvax
14.3.10 BIONEER CORPORATION
14.3.11 PCR Biosystems
14.3.12 PacBio
